The Company is a Korea-based company principally engaged in developing and manufacturing reagent used for experimentation . The Company s product portfolio consists of recombination proteins including binding immunoglobulin protein, carboxy terminus of HSP70 interacting protein, BCL2-associated athanogene 2; monoclonal antibodies including 14-3-3 beta antibody, A crystallin A antibody , alpha-crystallin B and NK Vue Kit used for physical examination and diagnosis. The Company distributes its products within domestic market and to overseas markets. The Company was established on January 14, 2002. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on October 23, 2015.
Headquarters
1F, 6F, 172, Dolma-Ro, Bundang-Gu, Seongnam-Si
Seongnam; Gyeonggi;
Postal Code: 13605
Contact Details: Purchase the Atgen Co.,Ltd. report to view the information.
Website: http://www.nkvue.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service